Jennifer E. Thorne
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jennifer E. Thorne has a total of 190 co-authors. Here are the top co-authors by number of shared publications:
Douglas A. Jabs
The Wilmer Eye Institute, Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Epidemiology, Center for Clinical Trials and Evidence Synthesis, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
18 shared publicationsJames P. Dunn
Department of Ophthalmology the Johns Hopkins University School of Medicine, Baltimore, Maryland
14 shared publicationsBryn M. Burkholder
From the Wilmer Eye Institute, the Department of Ophthalmology, the Johns Hopkins University School of Medicine (K.M., P.L., M.K.B., J.T.W., B.B.B., D.A.J., J.E.T), Baltimore, Maryland, USA
9 shared publicationsSanjay R. Kedhar
Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland
6 shared publicationsAshvini K. Reddy
The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland
4 shared publicationsGeorge B. Peters
Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland
4 shared publications
Latest Publications
- 25 January 2025
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 272, 98-105
Clinical Outcomes in Peripheral Ulcerative Keratitis
- 25 January 2025
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 272, 98-105
Clinical Outcomes in Peripheral Ulcerative Keratitis
- Open Access
- 20 March 2024
- Published by BMJ in British Journal of Ophthalmology
- Vol. 108 (11) , 1543-1547
Visual acuity and visual field as a function of disease duration in patients with birdshot chorioretinitis
Background Birdshot chorioretinitis (BSCR) is a chronic bilateral posterior uveitis, which can affect central as well as peripheral vision. The aim of this study was to assess how visual acuity and visual field evolved over time in patients with BSCR. Methods This was a prospective, observational, single-centre study based on data from the CO-BIRD cohort. Patient visits were categorised based on the time elapsed since the first symptoms, and groups of patients with different disease duration were defined. The main outcome measures were the best corrected visual acuity (BCVA), the mean deviation (MD) and the standard pattern deviation (PSD). Results The study included 447 Caucasian patients (181 males and 266 females), all of whom HLA-A29 carriers. From onset to 30 years of disease duration, the number of patients in each consecutive 5-year period was 237, 250, 196, 147, 78 and 32, respectively. Overall, the range of visual acuity and visual field results increased with disease duration. BCVA gradually decreased and showed a significant decline after 11–15 years after the first symptoms. Among the visual field indices, PSD significantly increased after 16–20 years, while MD showed a significant decline after 21–25 years. No major gender differences were found in visual outcomes, indicating comparable severity. The intereye correlations of MD and PSD were stronger than those of BCVA. Conclusions BSCR resulted in a large heterogeneity of visual outcomes, which increased with time. Our data provide an overview of the visual consequences of BSCR as a function of disease duration.
- 20 March 2024
- Published by BMJ in British Journal of Ophthalmology
- Vol. 108 (11) , 1543-1547
Open AccessVisual acuity and visual field as a function of disease duration in patients with birdshot chorioretinitis
Background Birdshot chorioretinitis (BSCR) is a chronic bilateral posterior uveitis, which can affect central as well as peripheral vision. The aim of this study was to assess how visual acuity and visual field evolved over time in patients with BSCR. Methods This was a prospective, observational, single-centre study based on data from the CO-BIRD cohort. Patient visits were categorised based on the time elapsed since the first symptoms, and groups of patients with different disease duration were defined. The main outcome measures were the best corrected visual acuity (BCVA), the mean deviation (MD) and the standard pattern deviation (PSD). Results The study included 447 Caucasian patients (181 males and 266 females), all of whom HLA-A29 carriers. From onset to 30 years of disease duration, the number of patients in each consecutive 5-year period was 237, 250, 196, 147, 78 and 32, respectively. Overall, the range of visual acuity and visual field results increased with disease duration. BCVA gradually decreased and showed a significant decline after 11–15 years after the first symptoms. Among the visual field indices, PSD significantly increased after 16–20 years, while MD showed a significant decline after 21–25 years. No major gender differences were found in visual outcomes, indicating comparable severity. The intereye correlations of MD and PSD were stronger than those of BCVA. Conclusions BSCR resulted in a large heterogeneity of visual outcomes, which increased with time. Our data provide an overview of the visual consequences of BSCR as a function of disease duration.
- Open Access
- 25 January 2024
- Published by Wolters Kluwer Health in Journal of Neuro-Ophthalmology
- Vol. 44 (4) , 545-551
Optic Disc Edema Is an Under-Recognized Feature of Birdshot Chorioretinitis
Background: Optic disc edema is a feature of many ophthalmic and neurologic conditions. It remains an underappreciated feature of birdshot chorioretinitis (BSCR), leading to delay in diagnosis and treatment. The purpose of our study was to identify clinical features that are concomitant with optic disc edema and suggest a diagnosis of BSCR. Methods: Retrospective multicenter case series of 29 patients who were referred to a neuro-ophthalmologist or uveitis specialist for evaluation of disc edema and were ultimately diagnosed with BSCR. Results: Fifty-four eyes of 30 patients, from the practices of 15 uveitis specialists, met the eligibility criteria. In addition to disc edema, concomitant features in all patients included vitritis, chorioretinal lesions, and retinal vasculitis. Visual recovery to 20/40 or better occurred in 26 of 29 patients. Visual acuity remained 20/100 or worse in 2 patients previously diagnosed with idiopathic intracranial hypertension, 1 patient previously diagnosed with optic neuritis, and 1 patient for whom treatment was delayed for years, leading to optic disc atrophy. Conclusions: Optic disc edema is a presenting feature in some cases of BSCR. A diagnosis of BSCR should be considered when disc edema occurs with vitritis, chorioretinal inflammation, and retinal vasculitis. Patients should be referred to a uveitis specialist for treatment.
- 25 January 2024
- Published by Wolters Kluwer Health in Journal of Neuro-Ophthalmology
- Vol. 44 (4) , 545-551
Open AccessOptic Disc Edema Is an Under-Recognized Feature of Birdshot Chorioretinitis
Background: Optic disc edema is a feature of many ophthalmic and neurologic conditions. It remains an underappreciated feature of birdshot chorioretinitis (BSCR), leading to delay in diagnosis and treatment. The purpose of our study was to identify clinical features that are concomitant with optic disc edema and suggest a diagnosis of BSCR. Methods: Retrospective multicenter case series of 29 patients who were referred to a neuro-ophthalmologist or uveitis specialist for evaluation of disc edema and were ultimately diagnosed with BSCR. Results: Fifty-four eyes of 30 patients, from the practices of 15 uveitis specialists, met the eligibility criteria. In addition to disc edema, concomitant features in all patients included vitritis, chorioretinal lesions, and retinal vasculitis. Visual recovery to 20/40 or better occurred in 26 of 29 patients. Visual acuity remained 20/100 or worse in 2 patients previously diagnosed with idiopathic intracranial hypertension, 1 patient previously diagnosed with optic neuritis, and 1 patient for whom treatment was delayed for years, leading to optic disc atrophy. Conclusions: Optic disc edema is a presenting feature in some cases of BSCR. A diagnosis of BSCR should be considered when disc edema occurs with vitritis, chorioretinal inflammation, and retinal vasculitis. Patients should be referred to a uveitis specialist for treatment.
- 24 February 2023
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 32 (5) , 616-620
Swept Source Optical Coherence Tomography Angiography Findings in Birdshot Chorioretinitis: A Cross Sectional Study of 21 Patients
Birdshot chorioretinitis (BSCR) is a form of posterior uveitis that is classically characterized by hypopigmented choroidal lesions outside of the major arcades. However, little is known about the ...
- 24 February 2023
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 32 (5) , 616-620
Swept Source Optical Coherence Tomography Angiography Findings in Birdshot Chorioretinitis: A Cross Sectional Study of 21 Patients
Birdshot chorioretinitis (BSCR) is a form of posterior uveitis that is classically characterized by hypopigmented choroidal lesions outside of the major arcades. However, little is known about the ...
- 23 April 2022
- Published by Springer Nature
- p. 4103-4116
Birdshot Chorioretinopathy
- 10 March 2022
- Published by Elsevier in Ophthalmology Retina
- Vol. 6 (7) , 620-627
Treatment Outcomes in Birdshot Chorioretinitis
- 10 March 2022
- Published by Elsevier in Ophthalmology Retina
- Vol. 6 (7) , 620-627
Treatment Outcomes in Birdshot Chorioretinitis
- 22 December 2021
- Published by Wolters Kluwer Health in Cornea
- Vol. 41 (5) , 644-646
Corneal Sarcoidosis: Diffuse Stromal Granulomatous Inflammation in a Patient With Sarcoidosis
Purpose: The purpose of this study was to present a case of diffuse noncaseating granulomas involving the corneal stroma in a patient with ocular and pulmonary sarcoidosis. Methods: This was a single case report. Results: A 31-year-old female patient presented with a 6-year history of panuveitis of the right eye along with a history of pulmonary sarcoidosis and a conjunctival biopsy of the right eye that was reported as positive for sarcoidosis. At presentation to our clinic, the patient had band keratopathy, vascularization of the inferonasal cornea, and active anterior uveitis of the right eye. When the patient returned for a follow-up of 15 months after the initial presentation, the cornea of the right eye exhibited widespread stromal scarring and vascularization. Because of the corneal scarring, the patient underwent an implantation of a Boston type 1 keratoprosthesis in the right eye. Histopathological examination of the host corneal tissue removed at the time of the keratoprosthesis procedure revealed extensive noncaseating granulomas in the deep corneal stroma. The patient underwent penetrating keratoplasty 8 months later, and histopathological examination again demonstrated noncaseating granulomas, this time at the edges of the donor corneal graft used during the keratoprosthesis implantation. Conclusions: We present the histopathological evidence of sarcoidosis involving the corneal stroma. Interestingly, the stromal keratitis also subsequently involved the donor cornea tissue after the patient underwent a keratoprosthesis implantation. It seems that sarcoidosis is a rare cause of stromal keratitis.
- 22 December 2021
- Published by Wolters Kluwer Health in Cornea
- Vol. 41 (5) , 644-646
Corneal Sarcoidosis: Diffuse Stromal Granulomatous Inflammation in a Patient With Sarcoidosis
Purpose: The purpose of this study was to present a case of diffuse noncaseating granulomas involving the corneal stroma in a patient with ocular and pulmonary sarcoidosis. Methods: This was a single case report. Results: A 31-year-old female patient presented with a 6-year history of panuveitis of the right eye along with a history of pulmonary sarcoidosis and a conjunctival biopsy of the right eye that was reported as positive for sarcoidosis. At presentation to our clinic, the patient had band keratopathy, vascularization of the inferonasal cornea, and active anterior uveitis of the right eye. When the patient returned for a follow-up of 15 months after the initial presentation, the cornea of the right eye exhibited widespread stromal scarring and vascularization. Because of the corneal scarring, the patient underwent an implantation of a Boston type 1 keratoprosthesis in the right eye. Histopathological examination of the host corneal tissue removed at the time of the keratoprosthesis procedure revealed extensive noncaseating granulomas in the deep corneal stroma. The patient underwent penetrating keratoplasty 8 months later, and histopathological examination again demonstrated noncaseating granulomas, this time at the edges of the donor corneal graft used during the keratoprosthesis implantation. Conclusions: We present the histopathological evidence of sarcoidosis involving the corneal stroma. Interestingly, the stromal keratitis also subsequently involved the donor cornea tissue after the patient underwent a keratoprosthesis implantation. It seems that sarcoidosis is a rare cause of stromal keratitis.
- 1 March 2021
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 223, 21-27
Disease Relapse After Drug-Free Remission in Ocular Mucous Membrane Pemphigoid
- 1 March 2021
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 223, 21-27
Disease Relapse After Drug-Free Remission in Ocular Mucous Membrane Pemphigoid
- 6 October 2020
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 30 (3) , 741-749
Effectiveness of the Dexamethasone Implant in Lieu of Oral Corticosteroids in Intermediate and Posterior Uveitis Requiring Immunosuppression
To evaluate dexamethasone intravitreal implant effectiveness in lieu of high-dose oral prednisone for short-term treatment of noninfectious intermediate and posterior uveitis in patients requiring ...
- 6 October 2020
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 30 (3) , 741-749
Effectiveness of the Dexamethasone Implant in Lieu of Oral Corticosteroids in Intermediate and Posterior Uveitis Requiring Immunosuppression
To evaluate dexamethasone intravitreal implant effectiveness in lieu of high-dose oral prednisone for short-term treatment of noninfectious intermediate and posterior uveitis in patients requiring ...
- 22 July 2020
- Published by Springer Nature
- p. 1-14
Birdshot Chorioretinopathy